| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Feb―07 |
Causal effects of COVID-19 on the risk of thrombosis: A Two-Sample Mendel Randomization Study |
Zhengran Li, Minghui Zeng, Tong Wu, Zijin Wang, Yuxin Sun, Ziran Zhang, Fanye Wu, Zejun Chen, Fangke Meng, Min Fu |
| 2 |
[GO] |
2024―Jan―25 |
ADAMTS13 or Caplacizumab Reduces the Accumulation of Neutrophil Extracellular Traps and Thrombus in Whole Blood of COVID-19 Patients under Flow |
Noritaka Yada, Quan Zhang, Antonia Bignotti, Zhan Ye, X. Long Zheng |
| 3 |
[GO] |
2023―Nov―23 |
Antithrombotic prophylaxis with rivaroxaban in patients with prehospital COVID-19: A meta-analysis of two placebo-controlled trials |
Judith Hsia, Alex C. Spyropoulos, Gregory Piazza, Stephen Weng, Michael Dunne, Concetta Lipardi, Elliot Barnathan, Marc Bonaca |
| 4 |
[GO] |
2023―Nov―16 |
COVID-19 and Long-COVID Thrombosis: From Clinical and Basic Science to Therapeutics |
Francesco Violi, Job Harenberg, Pasquale Pignatelli, Vittoria Cammisotto |
| 5 |
[GO] |
2023―Nov―07 |
Protease-activated receptor-1 IgG autoantibodies in patients with COVID-19 |
Leander Reinshagen, Vanasa Nageswaran, Harald Heidecke, Kai Schulze-Forster, Anne-Christin Beatrice Wilde, Pegah Ramezani Rad, Wolfgang Poller, Erik Asmus, Szandor Simmons, Wolfgang M. Kuebler, Martin Witzenrath, Lajos Marko, Kai Jakobs, David M. Leistner, Ursula Rauch-Kröhnert, Nicolle Kränkel, Sofia K. Forslund, Ulf Landmesser, Dominik N. Müller, Arash Haghikia |
| 6 |
[GO] |
2023―May―12 |
Pathophysiological Aspects of COVID-19-Associated Vasculopathic Diseases |
Thiemo Greistorfer, Philipp Jud |
| 7 |
[GO] |
2023―May―05 |
Risk factors for post-discharge major thromboembolism and mortality in hospitalized patients with COVID-19 with cardiovascular comorbidities |
Dimitrios Giannis, Mark Goldin, Husneara Rahman, Cristina P Sison, Martin Lesser, Sam Ngu, James Tsang, Michael Qiu, Shreya Sanghani, Jackson Yeh, Miltiadis Matsagkas, Eleni Arnaoutoglou, Alex C. Spyropoulos |
| 8 |
[GO] |
2023―Apr―12 |
Low α-thrombin/GPIbα interaction is a potential contributor to platelet hyper-reactivity in COVID-19 patients |
Younes Zaid, Loubna Khalki, Farid Jalali, Youssef Tijani, Nabil Zaid, Abdallah Naya, Mounia Oudghiri, Khadija Akarid, Ejaife O. Agbani, Fadila Guessous |
| 9 |
[GO] |
2023―Mar―21 |
Atorvastatin versus Placebo in ICU Patients with COVID-19: Ninety-day Results of the INSPIRATION-S Trial |
Azita Hajhossein Talasaz, Parham Sadeghipour, Hooman Bakhshandeh, Babak Sharif-Kashani, Farid Rashidi, Mohammad Taghi Beigmohammadi, Keivan Gohari Moghadam, Somayeh Rezaian, Ali Dabbagh, Seyed Hashem Sezavar, Mohsen Farrokhpour, Atefeh Abedini, Rasoul Aliannejad, Taghi Riahi, Mahdi Yadollahzadeh, Somayeh Lookzadeh, Parisa Rezaeifar, Samira Matin, Ooria Tahamtan, Keyhan Mohammadi, Elnaz Zoghi, Hamid Rahmani, Seyed Hossein Hosseini, Seyed Masoud Mousavian, Homa Abri, Pardis Sadeghipour, Elahe Baghizadeh, Farnaz Rafiee, Sepehr Jamalkhani, Ahmad Amin, Bahram Mohebbi, Seyed Ehsan Parhizgar, Mahshid Soleimanzadeh, Maryam Aghakouchakzadeh, Vahid Eslami, Pooya Payandemehr, Hossein Khalili, Hamed Talakoob, Taranom Tojari, Shadi Shafaghi, Sanaz Tabrizi, Hessam Kakavand, Alireza Kashefizadeh, Atabak Najafi, David Jiménez, Aakriti Gupta, Mahesh V Madhavan, Sanjum Sethi, Sahil A Parikh, Manuel Monreal, Naser Hadavand, Alireza Hajighasemi, Khalil Ansarin, Majid Maleki, Saeed Sadeghian, Stefano Barco, Bob Siegerink, Erica Spatz, Gregory Piazza, Ajay J Kirtane, Benjamin W Van Tassell, Gregory YH Lip, Erik Klok, Samuel Z Goldhaber, Gregg Stone, Harlan Krumholz, Behnood Bikdeli |
| 10 |
[GO] |
2022―Dec―21 |
SARS-CoV-2 vaccination: Long-Term Follow-up of Pre-Existing and De Novo Immune Thrombocytopenia (ITP) |
Marina Beltrami Moreira, James B. Bussel, Eun-Ju Lee |
| 11 |
[GO] |
2022―Oct―17 |
Increased Von Willebrand factor platelet-binding capacity is related to poor prognosis in COVID-19 patients. |
lucia stefanini, Franco Ruberto, Mariaignazia Curreli, Antonio CHISTOLINI, Eleonora Schiera, Ramona Marrapodi, Marcella Visentini, Giancarlo Ceccarelli, Gabriella D'Ettorre, Cristina Santoro, Orietta Gandini, Emilia F Moro, Veronica Zullino, Francesco Pugliese, Fabio Pulcinelli |
| 12 |
[GO] |
2022―Oct―11 |
Hyperresponsive Platelets and a Reduced Platelet Granule Release Capacity Are Associated with Severity and Mortality in COVID-19 Patients |
Fadel Muhammad Garishah, Dana Huskens, Setyo Gundi Pramudo, Dessy Andriani, Mila Astrilia, Rizki Akbar Sentosa, André J. A. M. van der Ven, Bas de Laat, Muhammad Hussein Gasem, Quirijn de Mast, Mark Roest |
| 13 |
[GO] |
2022―Oct―07 |
Knowledge gaps for prophylactic antithrombotic agents use in patients with COVID-19: Insights on new variants, vaccination and emerging antivirals |
Azita Hajhossein Talasaz, Parham Sadeghipour, Kasra Mehdizadeh, Niloofar Khoshnam Rad, Behnood Bikdeli, Gregory YH Lip, Job Harenberg |
| 14 |
[GO] |
2022―Jul―18 |
The Platelet Lipidome Is Altered in Patients with COVID-19 and Correlates with Platelet Reactivity |
Alex R. Schuurman, Valentine Léopold, Liza Pereverzeva, Osoul Chouchane, Tom D. Y. Reijnders, Justin de Brabander, Renée A. Douma, Michel van Weeghel, Eric Wever, Bauke V. Schomaker, Frédéric M. Vaz, Willem Joost Wiersinga, Cornelis van't Veer, Tom van der Poll |
| 15 |
[GO] |
2022―May―30 |
Autoimmune acquired factor XIII/13 deficiency after SARS-CoV-2 mRNA vaccination |
Shingen Nakamura, Motoki Sugasaki, Masayoshi Souri, Hirohito Akazawa, Maiko Sogawa, Taiki Hori, Hiroki Yamagami, Makoto Takishita, Ken-ichi Aihara, Masahiro Abe, Atsushi Yasumoto, Eriko Morishita, Akitada Ichinose |
| 16 |
[GO] |
2022―Apr―04 |
Pentosan polysulfate - A ‘better heparin’ as potential medication for the treatment of SARS-CoV-2 infections? |
Gerd Bendas |
| 17 |
[GO] |
2022―Mar―24 |
Pentosan polysulfate inhibits attachment and infection by SARS-CoV-2 in vitro: insights into structural requirements for binding |
Sabrina Bertini, Anna Alekseeva, Stefano Elli, Isabel Pagani, Serena Zanzoni, Giorgio Eisele, Ravi Krishnan, Klaus P Maag, Christian Reiter, Dominik Lenhart, Rudolf Gruber, Edwin Yates, Elisa Vicenzi, Annamaria Naggi, Antonella Bisio, Marco Guerrini |
| 18 |
[GO] |
2022―Mar―15 |
One Year Prevalence of Venous Thromboembolism in Hospitalized COVID-19 Patients in France: Patients' Characteristics, Time Trends, and Outcomes |
Amélie Gabet, Clémence Grave, Philippe Tuppin, Valérie Olié, Joseph Emmerich |
| 19 |
[GO] |
2022―Mar―07 |
Assessing clinically meaningful hypercoagulability after COVID-19 Vaccination: a longitudinal study |
Elena Campello, Cristiana Bulato, Chiara Simion, Luca Spiezia, Claudia Maria Radu, Sabrina Gavasso, Francesca Sartorello, Graziella Saggiorato, Patrizia Zerbinati, Mariangela Fadin, daniela tormene, Paolo Simioni |
| 20 |
[GO] |
2022―Mar―07 |
THE ADA (AGE-D-DIMER-ALBUMIN) SCORE TO PREDICT THROMBOSIS IN SARS-CoV-2. |
Francesco Violi, Pasquale Pignatelli, Annarita Vestri, Alessandra Spagnoli, Francesco Cipollone, Giancarlo Ceccarelli, Alessandra Oliva, maria amitrano, Matteo Pirro, Gloria Taliani, Roberto Cangemi, Miriam Lichtner, Francesco Pugliese, Marco Falcone, Mario Venditti, Claudio Maria Mastroianni, Lorenzo Loffredo |
| 21 |
[GO] |
2022―Mar―04 |
The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists |
Chantal Visser, Joseph S. Biedermann, Melchior C. Nierman, Felix J.M. van der Meer, Anouk J.W. Gulpen, Yvonne C.F. Moors, Suzanne C. Cannegieter, Willem M. Lijfering, Marieke J.H.A. Kruip |
| 22 |
[GO] |
2022―Feb―11 |
Adjusting D-dimer to lung disease extent to exclude Pulmonary Embolism in COVID-19 patients (Co-LEAD) |
Benjamin Planquette, Lina Khider, Alice Le Berre, Simon Soudet, Gilles Pernod, Raphael Le Mao, Matthieu Besutti, Nicolas Gendron, Alexandra Yannoutsos, David M Smadja, Guillaume Goudot, Salma Al Kahf, Nassim Mohammedi, Antoine Al Hamoud, Aurélien Philippe, Laure Fournier, Bastien Rance, Jean-Luc Diehl, Tristan Mirault, Emmanuel Messas, Joseph Emmerich, Richard Chocron, Francis Couturaud, Gilbert Ferreti, marie-antoinette sevestre-pietri, nicolas meneveau, Gilles Chatellier, Olivier Sanchez |
| 23 |
[GO] |
2022―Jan―21 |
Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality |
György Sinkovits, Marienn Réti, Veronika Müller, Zsolt Iványi, János Gál, László Gopcsa, Péter Reményi, Beáta Szathmáry, Botond Lakatos, János Szlávik, Ilona Bobek, Zita Z. Prohászka, Zsolt Förhécz, Blanka Mező, Dorottya Csuka, Lisa Hurler, Erika Kajdácsi, László Cervenak, Petra Kiszel, Tamás Masszi, István Vályi-Nagy, Zoltán Prohászka |
| 24 |
[GO] |
2021―Nov―18 |
Heterogeneity of vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination and safety of second vaccination with BNT162b2 |
Edelgard Lindhoff-Last, Linda Schoenborn, Michael Piorkowski, Joerg Herold, Andreas Greinacher, Jo-Ann Sheppard, Theodore Warkentin |
| 25 |
[GO] |
2021―Nov―10 |
Comparison of thrombotic events and mortality in patients with community-acquired pneumonia and COVID-19: a multicentre observational study |
Roberto Cangemi, camilla calvieri, Marco Falcone, Francesco Cipollone, Giancarlo Ceccarelli, Pasquale Pignatelli, Damiano D'Ardes, Matteo Pirro, Francesco Alessandri, Miriam Lichtner, Gabriella D'Ettorre, Alessandra Oliva, Raissa Aronica, Monica Rocco, Mario Venditti, Giulio Francesco Romiti, Giusy Tiseo, Gloria Taliani, Francesco Menichetti, Francesco Pugliese, Claudio Maria Mastroianni, Francesco Violi |
| 26 |
[GO] |
2021―Nov―03 |
Activated Platelets Harbour SARS-CoV-2 During Severe COVID-19 |
Ejaife O. Agbani, Prism Schneider, Braedon McDonald, Leslie Skeith, Man-Chiu Poon, Adrienne Lee |
| 27 |
[GO] |
2021―Oct―13 |
Therapeutic vs. prophylactic bemiparin in hospitalized patients with non-severe COVID-19 (BEMICOP): an open-label, multicenter, randomized trial |
María Marcos, Francisco Carmona-Torre, Rosa Vidal Laso, PEDRO RUIZ-ARTACHO, David Filella, Cristina Carbonell, Victor Jimenez-Yuste, Juana Schwartz, Pilar Llamas, Félix Alegre, Belén Sádaba, Jorge Núñez-Córdoba, José Ramón Yuste, Javier Fernández-García, Ramón Lecumberri |
| 28 |
[GO] |
2021―Sep―30 |
Acquired autoimmune Haemophilia following SARS-CoV-2 vaccines: Dual drug effects on blood coagulation and the Scylla and Charybdis
phenomenon |
Job Harenberg, Marina Marchetti, Anna Falanga |
| 29 |
[GO] |
2021―Sep―06 |
Mild COVID-19 and Impaired Blood Cell-Endothelial Crosstalk: Considering Long-Term Use of Antithrombotics? |
Arthur Melkumyants, Ludmila Buryachkovskaya, Nikita Lomakin, Olga Antonova, Victor Serebruany |
| 30 |
[GO] |
2021―Aug―12 |
Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination |
Nadia Gabarin, Sarah Patterson, Menaka Pai, Tamoor Afzaal, Ishac Nazy, Jo-Ann Sheppard, Donald M. Arnold, Theodore Warkentin |
| 31 |
[GO] |
2021―Aug―05 |
Autoimmunity After Coronavirus Disease 2019 (COVID-19) Vaccine: A Case of Acquired Hemophilia A |
Scott Farley, Robert Ousley, Nicholas Van Wagoner, Fernando Bril |
| 32 |
[GO] |
2021―Aug―05 |
Modeling the effects of intravasal administration of AstraZeneca ChAdOx1 nCoV-19 vaccine on human platelets |
Pernille Just Vinholt, Henrik Frederiksen, Christian Nielsen |
| 33 |
[GO] |
2021―Jun―25 |
COVID-19 PANDEMIC UPDATES AND PERSPECTIVES. NEED FOR AN INTEGRATED AND EQUITABLE APPROACH. |
Grigoris Gerotziafas, Mariella Catalano, Ioannis Theodorou, Patrick van Dreden, Vincent Marechal, Alex Spyropoulos, Chalres Carter, Nusrat Jabeen, Job Harenberg, Ismail Elalamy, Anna Falanga, Jawed Fareed |
| 34 |
[GO] |
2021―Jun―15 |
ECMO induces early alterations in coagulation and fibrinolysis profiles in COVID-19 patients with acute respiratory distress syndrome. |
Guillaume Hékimian, Paul Masi, Manon Lejeune, Guillaume Lebreton, Juliette Chommeloux, Cyrielle Desnos, Marc Pineton De Chambrun, Isabelle Martin-Toutain, Ania Nieszkowska, Nicolas Bréchot, Matthieu Schmidt, Pascal Leprince, Charles-Edouard Luyt, Alain Combes, Corinne Frère |
| 35 |
[GO] |
2021―Jun―07 |
COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases. |
Ippazio Cosimo Antonazzo, Carla Fornari, olga Paoletti, Claudia Bartolini, Sara Conti, Paolo Angelo Cortesi, Lorenzo Mantovani, Rosa Gini, Giampiero Mazzaglia |
| 36 |
[GO] |
2021―Jun―03 |
Extracellular vesicles and citrullinated histone H 3 in coronavirus disease 2019 (COVID-19) patients |
Ludwig Traby, Marietta Kollars, Manuel Kussmann, Matthias Karer, Hana Sinkovec, Elisabeth Lobmeyr, Alexander Hermann, Thomas Staudinger, Peter Schellongowski, Bernhard Rössler, Heinz Burgmann, Paul Alexander Kyrle, Sabine Eichinger |
| 37 |
[GO] |
2021―May―07 |
COVID-19 and atrial fibrillation in older patients. Does oral anticoagulant therapy provide a survival benefit? An insight from the GeroCovid Registry |
Stefano Fumagalli, Caterina Trevisan, Susanna Del Signore, Giulia Pelagalli, Stefano Volpato, Pietro Gareri, Enrico Mossello, Alba Malara, Fabio Monzani, Alessandra Coin, Giuseppe Bellelli, Gianluca Zia, Raffaele Antonelli Incalzi |
| 38 |
[GO] |
2021―May―04 |
SARS-CoV-2 vaccine and thrombosis: Expert opinions |
Ismail Elalamy, Grigoris Gerotziafas, Sonia ALAMOWITCH, Jean-Pierre LAROCHE, Patrick van Dreden, Walter Ageno, Jan Beyer-Westendorf, Alexander T Cohen, David Jiménez, Benjamin Brenner, Saskia Middeldorp, Patrice Cacoub |
| 39 |
[GO] |
2021―Apr―21 |
More on the source of D-dimer in COVID-19 |
Hau C Kwaan, Andrew P Mazar |
| 40 |
[GO] |
2021―Apr―17 |
Intermediate vs Standard-dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to ICU: Ninety-day Results from the INSPIRATION Trial |
Behnood Bikdeli, Azita H Talasaz, Farid Rashidi, Hooman Bakhshandeh, Farnaz Rafiee, Samira Matin, Elahe Baghizadeh, Parisa Rezaeifar, Sepehr Jamalkhani, Ooria Tahamtan, Babak Sharif-Kashani, Mohammad Taghi Beigmohammadi, Mohsen Farrokhpour, Seyed Hashem Sezavar, Pooya Payandemehr, Ali Dabbagh, Keivan Gohari Moghadam, Hossein Khalili, Mahdi Yadollahzadeh, Taghi Riahi, Atefeh Abedini, Somayeh Lookzadeh, Hamid Rahmani, Elnaz Zoghi, Keyhan Mohammadi, Pardis Sadeghipour, Homa Abri, Sanaz Tabrizi, Seyed Masoud Mousavian, Shaghayegh Shahmirzaei, Ahmad Amin, Bahram Mohebbi, Seyed Ehsan Parhizgar, Rasoul Aliannejad, Vahid Eslami, Alireza Kashefizadeh, Paul Dobesh, Hessam Kakavand, Seyed Hossein Hosseini, Shadi Shafaghi, Samrand Fattah Ghazi, Atabak Najafi, David Jiménez, Aakriti Gupta, Mahesh V Madhavan, Sanjum Sethi, Sahil A Parikh, Manuel Monreal, Naser Hadavand, Alireza Hajighasemi, Majid Maleki, Saeed Sadeghian, Gregory Piazza, Ajay J Kirtane, Benjamin W Van Tassell, Gregg W Stone, Gregory YH Lip, Harlan Krumholz, Samuel Z Goldhaber, Parham Sadeghipour |
| 41 |
[GO] |
2021―Apr―08 |
Platelet count rose while D-dimer levels dropped as deaths and thrombosis declined, an observational study on anticoagulation shift in COVID-19 |
Anna Sjöström, Johanna Wersäll, Anna Warnqvist, Maria Farm, Maria Magnusson, Anders Oldner, Anna Ågren, Jovan P Antovic, Maria Bruzelius |
| 42 |
[GO] |
2021―Apr―08 |
Anticoagulant treatment of COVID-19 as early as possible - Sulodexide and perspectives |
Sam Schulman, Job Harenberg |
| 43 |
[GO] |
2021―Apr―08 |
Significant major bleeding in hospitalized patients with COVID-19 receiving thromboprophylaxis |
Vicky Mai, Sabine Mainbourg, Boun Kim Tan, Jean-Christophe Lega, Steeve Provencher |
| 44 |
[GO] |
2021―Apr―06 |
Treatment-dose LMWH versus prophylactic/intermediate dose heparins in high risk COVID-19 inpatients: Rationale and design of the HEP-COVID Trial |
Mark Goldin, Dimitrios Giannis, Wassim Diab, Janice Wang, Sameer Khanijo, Gulru Sharifova, Marc Cohen, Jeet M Lund, Andrea Mignatti, Eugenia Gianos, alfonso tafur, Paul A Lewis, Kevin Cohoon, John M Kittelson, Martin Lesser, Cristina P Sison, Husneara Rahman, Kanta Ochani, William Hiatt, Rita A Dale, Victoria E Anderson, Marc Bonaca, Jonathan L Halperin, Jeffrey I Weitz, Alex Spyropoulos |
| 45 |
[GO] |
2021―Mar―20 |
COVID-19 is associated with an acquired factor XIII deficiency. |
Fien von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, Annika Lundstrom, Maria Magnusson, Nigel Mackman, Charlotte Thalin, Ton Lisman |
| 46 |
[GO] |
2021―Mar―07 |
Sulodexide in the treatment of patients with early stages of COVID-19: a randomized controlled trial |
Alejandro jose Gonzalez Ochoa, Joseph Raffetto, Ana Gabriela Hernandez Ibarra, Nestor Zavala, Obed Gutierrez, Arturo Vargas, Jorge Loustaunau |
| 47 |
[GO] |
2021―Feb―26 |
Severe SARS-CoV-2 infection inhibits fibrinolysis leading to changes in viscoelastic properties of blood clot: A descriptive study of fibrinolysis |
Stefanie Hammer, Helene Haeberle, Christian Schlensak, Michael Bitzer, Nisar Malek, Rupert Handgretinger, Peter Lang, Sebastian Hörber, Andreas Peter, Peter Martus, Valbona Mirakaj, Meinrad Gawaz, Tobias Geisler, Karina Althaus, Peter Rosenberger, Tamam Bakchoul |
| 48 |
[GO] |
2021―Feb―07 |
Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study |
Andrea Artoni, Mauro Panigada, Stefano Ghirardello, Anna Lecchi, Stefano Aliberti, Erica Scalambrino, Silvia La Marca, Marco Boscarino, Andrea Gramegna, Paolo Properzi, Chiara Abruzzese, Francesco Blasi, Giacomo Grasselli, Fabio Mosca, Armando Tripodi, Flora Peyvandi |
| 49 |
[GO] |
2021―Jan―21 |
Waves of SARS-CoV-2 Infection and Blood Coagulation-A Link and Beyond |
Job Harenberg, Francesco Violi |
| 50 |
[GO] |
2021―Jan―20 |
Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients |
Stuart Lance Cohen, Eugenia Gianos, Matthew A Barish, Saurav Chatterjee, Nina Kohn, Martin Lesser, Dimitrios Giannis, Kevin Coppa, Jamie Hirsch, Thomas McGinn, Mark Goldin, Alex Spyropoulos |
| 51 |
[GO] |
2021―Jan―07 |
Platelets are hyperactivated but show reduced glycoprotein VI reactivity in COVID-19 patients. |
Valentine Léopold, Liza Pereverzeva, Alex R. Schuurman, Tom D.Y. Reijnders, Anno Saris, Justin de Brabander, Christine C.A. van Linge, Renée A. Douma, Osoul Chouchane, Rienk Nieuwland, Willem Joost Wiersinga, Cornelis van ’t Veer, Tom van der Poll |
| 52 |
[GO] |
2021―Jan―07 |
Heparin in COVID-19 patients is associated with reduced in-hospital mortality: the multicentre Italian CORIST Study |
Augusto Filippo Di Castelnuovo, Simona Costanzo, Licia Iacoviello |
| 53 |
[GO] |
2021―Jan―05 |
Haemostasis in coronavirus disease 2019 - lesson from viscoelastic methods: a systematic review |
Artur Slomka, Mariusz Kowalewski, Ewa Żekanowska |
| 54 |
[GO] |
2020―Dec―31 |
Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis |
Rushad Patell, Thita Chiasakul, Ethan Bauer, Jeffrey I. Zwicker |
| 55 |
[GO] |
2020―Dec―23 |
Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report |
Francesco Violi, Giancarlo Ceccarelli, Lorenzo Loffredo, Francesco Alessandri, Francesco Cipollone, Damiano D'ardes, Gabriella D'Ettorre, Pasquale Pignatelli, Mario Venditti, Claudio Maria Mastroianni, Francesco Pugliese |
| 56 |
[GO] |
2020―Dec―23 |
Hypercoagulopathy in Severe COVID-19: Implications for Acute Care |
Alicia A. C. Waite, David O. Hamilton, Roberto Pizzi, Walter Ageno, Ingeborg D. Welters |
| 57 |
[GO] |
2020―Dec―23 |
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin |
Courtney J. Mycroft-West, Dunhao Su, Isabel Pagani, Timothy R. Rudd, Stefano Elli, Neha S. Gandhi, Scott E. Guimond, Gavin J. Miller, Maria C. Z. Meneghetti, Helena B. Nader, Yong Li, Quentin M. Nunes, Patricia Procter, Nicasio Mancini, Massimo Clementi, Antonella Bisio, Nicholas R. Forsyth, Vito Ferro, Jeremy E. Turnbull, Marco Guerrini, David G. Fernig, Elisa Vicenzi, Edwin A. Yates, Marcelo A. Lima, Mark A. Skidmore |
| 58 |
[GO] |
2020―Dec―10 |
Contrast between Prevalence of HIT Antibodies and Confirmed HIT in Hospitalized COVID-19 Patients: A Prospective Study with Clinical Implications |
Maxime Delrue, Virginie Siguret, Marie Neuwirth, Caren Brumpt, Sebastian Voicu, Ruxandra Burlacu, Damien Sène, Benjamin G. Chousterman, Nassim Mohamedi, Thomas Lecompte, Bruno Mégarbane, Alain Stépanian |
| 59 |
[GO] |
2020―Nov―20 |
Course of D-Dimer and C-Reactive Protein Levels in Survivors and Nonsurvivors with COVID-19 Pneumonia: A Retrospective Analysis of 577 Patients |
Luca Valerio, Paola Ferrazzi, Clara Sacco, Wolfram Ruf, Nils Kucher, Stavros V. Konstantinides, Stefano Barco, Corrado Lodigiani |
| 60 |
[GO] |
2020―Nov―13 |
Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality |
Henny H. Billett, Morayma Reyes-Gil, James Szymanski, Kenji Ikemura, Lindsay R. Stahl, Yungtai Lo, Shafia Rahman, Jesus D. Gonzalez-Lugo, Margarita Kushnir, Mohammad Barouqa, Ladan Golestaneh, Eran Bellin |
| 61 |
[GO] |
2020―Oct―30 |
Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19 |
Selin Gencer, Michael Lacy, Dorothee Atzler, Emiel P. C. van der Vorst, Yvonne Döring, Christian Weber |
| 62 |
[GO] |
2020―Oct―30 |
Neutrophil-Platelet and Monocyte-Platelet Aggregates in COVID-19 Patients |
Alexandre Le Joncour, Lucie Biard, Mathieu Vautier, Helene Bugaut, Arsene Mekinian, Georgina Maalouf, Matheus Vieira, Anne-Geneviève Marcelin, Michelle Rosenzwajg, David Klatzmann, Jean-Christophe Corvol, Olivier Paccoud, Aude Carillion, Joe-Elie Salem, Patrice Cacoub, Yacine Boulaftali, David Saadoun |
| 63 |
[GO] |
2020―Oct―24 |
Venous Thromboembolism in COVID-19 |
Sam Schulman, Yu Hu, Stavros Konstantinides |
| 64 |
[GO] |
2020―Sep―22 |
Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19 |
Grigoris T. Gerotziafas, Theodoros N. Sergentanis, Guillaume Voiriot, Ludovic Lassel, Chryssa Papageorgiou, Alexandre Elabbadi, Matthieu Turpin, Patrick Vandreden, Loula Papageorgiou, Theodora Psaltopoulou, Evangelos Terpos, Meletios-Athanasios Dimopoulos, Antoine Parrot, Jacques Cadranel, Gilles Pialoux, Muriel Fartoukh, Ismail Elalamy |
| 65 |
[GO] |
2020―Sep―13 |
The Multiple Faces of Heparin: Opportunities in COVID-19 Infection and Beyond |
Ludovic Drouet, Job Harenberg, Giangiacomo Torri |
| 66 |
[GO] |
2020―Sep―13 |
Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine |
Grigoris T. Gerotziafas, Mariella Catalano, Mary-Paula Colgan, Zsolt Pecsvarady, Jean Claude Wautrecht, Bahare Fazeli, Dan-Mircea Olinic, Katalin Farkas, Ismail Elalamy, Anna Falanga, Jawed Fareed, Chryssa Papageorgiou, Rosella S. Arellano, Petros Agathagelou, Darco Antic, Luciana Auad, Ljiljana Banfic, John R. Bartolomew, Bela Benczur, Melissa B. Bernardo, Francesco Boccardo, Renate Cifkova, Benilde Cosmi, Sergio De Marchi, Evangelos Dimakakos, Meletios A. Dimopoulos, Gabriel Dimitrov, Isabelle Durand-Zaleski, Michael Edmonds, Essam Abo El Nazar, Dilek Erer, Omar L. Esponda, Paolo Gresele, Michael Gschwandtner, Yongquan Gu, Mónica Heinzmann, Naomi M. Hamburg, Amer Hamadé, Noor-Ahmed Jatoi, Oguz Karahan, Debora Karetova, Thomas Karplus, Peter Klein-Weigel, Endre Kolossvary, Matija Kozak, Eleftheria Lefkou, Gianfranco Lessiani, Aaron Liew, Antonella Marcoccia, Peter Marshang, George Marakomichelakis, Jiri Matuska, Luc Moraglia, Sergio Pillon, Pavel Poredos, Manlio Prior, David Raymund K. Salvador, Oliver Schlager, Gerit Schernthaner, Alexander Sieron, Jonas Spaak, Alex Spyropoulos, Muriel Sprynger, Dusan Suput, Agata Stanek, Viera Stvrtinova, Andrzej Szuba, Alfonso Tafur, Patrick Vandreden, Panagiotis E. Vardas, Dragan Vasic, Miikka Vikkula, Paul Wennberg, Zhenguo Zhai |
| 67 |
[GO] |
2020―Sep―01 |
Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients |
Michael Hultström, Robert Frithiof, Oskar Eriksson, Barbro Persson, Miklos Lipcsey, Kristina Nilsson Ekdahl, Bo Nilsson |
| 68 |
[GO] |
2020―Aug―30 |
Staging Severity of COVID-19 according to Hemostatic Abnormalities (CAHA Score) |
Benjamin Marchandot, Antonin Trimaille, Anaïs Curtiaud, Adrien Carmona, Kensuke Matsushita, Chisato Sato, Ian Leonard-Lorant, Laurent Sattler, Lelia Grunebaum, Mickaël Ohana, Patrick Ohlmann, Laurence Jesel, Olivier Morel |
| 69 |
[GO] |
2020―Aug―24 |
Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus |
Upendra K. Katneni, Aikaterini Alexaki, Ryan C. Hunt, Tal Schiller, Michael DiCuccio, Paul W. Buehler, Juan C. Ibla, Chava Kimchi-Sarfaty |
| 70 |
[GO] |
2020―Aug―22 |
Variability in Institutional Guidance for COVID-19-Associated Coagulopathy in the United States |
Rushad Patell, Shonali Midha, Stephen Kimani, Richard Martin, Natalia Neparidze, Michael Jaglal, Jason Freed, Nigel S. Key |
| 71 |
[GO] |
2020―Jul―29 |
A Liaison between Sudden Sensorineural Hearing Loss and SARS-CoV-2 Infection |
Job Harenberg, Jost B. Jonas, Eleonora M. C. Trecca |
| 72 |
[GO] |
2020―Jul―23 |
Different Hypercoagulable Profiles in Patients with COVID-19 Admitted to the Internal Medicine Ward and the Intensive Care Unit |
Luca Spiezia, Annalisa Boscolo, Christelle Correale, Nicolò Sella, Elisa Pesenti, Luca Beghetto, Elena Campello, Francesco Poletto, Lorenzo Cerruti, Marco Cola, Alessandro De Cassai, Laura Pasin, Serra Eugenio, Roberto Vettor, Anna Maria Cattelan, Paolo Simioni, Paolo Navalesi |
| 73 |
[GO] |
2020―Jul―17 |
Prevalence and Impact of Coagulation Dysfunction in COVID-19 in China: A Meta-Analysis |
Shanen Jin, Yiyang Jin, Bai Xu, Jun Hong, Xianghong Yang |
| 74 |
[GO] |
2020―Jul―17 |
Obesity and COVID-19: A Virchow's Triad for the 21st Century |
Carl J. Vaughan, Heather Cronin, Paul MacDaragh Ryan, Noel M. Caplice |
| 75 |
[GO] |
2020―Jul―17 |
Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry |
Rahul Chaudhary, Rolf P. Kreutz, Kevin P. Bliden, Udaya S. Tantry, Paul A. Gurbel |
| 76 |
[GO] |
2020―Jul―09 |
Fibrinolysis Resistance: A Potential Mechanism Underlying COVID-19 Coagulopathy |
Emmanuel Weiss, Olivier Roux, Jean-Denis Moyer, Catherine Paugam-Burtz, Larbi Boudaoud, Nadine Ajzenberg, Dorothée Faille, Emmanuelle de Raucourt |
| 77 |
[GO] |
2020―Jun―23 |
Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection: Time to Rethink |
Nuccia Morici, Maurizio Bottiroli, Roberto Fumagalli, Claudia Marini, Marco Cattaneo |
| 78 |
[GO] |
2020―May―30 |
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research |
Mahesh V. Madhavan, Behnood Bikdeli, Aakriti Gupta, David Jimenez, John R. Burton, Caroline Der Nigoghossian, Taylor Chuich, Shayan Nabavi Nouri, Isaac Dreyfus, Elissa Driggin, Sanjum Sethi, Kartik Sehgal, Saurav Chatterjee, Walter Ageno, Mohammad Madjid, Yutao Guo, Liang V. Tang, Yu Hu, Laurent Bertoletti, Jay Giri, Mary Cushman, Isabelle Quéré, Evangelos P. Dimakakos, C Michael Gibson, Giuseppe Lippi, Emmanuel J. Favaloro, Jawed Fareed, Alfonso J. Tafur, Dominic P. Francese, Jaya Batra, Anna Falanga, Kevin J. Clerkin, Nir Uriel, Ajay Kirtane, Claire McLintock, Beverley J. Hunt, Alex C. Spyropoulos, Geoffrey D. Barnes, John W. Eikelboom, Ido Weinberg, Sam Schulman, Marc Carrier, Gregory Piazza, Joshua A. Beckman, Martin B. Leon, Gregg W. Stone, Stephan Rosenkranz, Samuel Z. Goldhaber, Sahil A. Parikh, Manuel Monreal, Harlan M. Krumholz, Stavros V. Konstantinides, Jeffrey I. Weitz, Gregory Y. H. Lip |
| 79 |
[GO] |
2020―May―26 |
Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy |
Betti Giusti, Anna Maria Gori, Manuel Alessi, Angela Rogolino, Elena Lotti, Daniela Poli, Elena Sticchi, Alessandro Bartoloni, Alessandro Morettini, Carlo Nozzoli, Adriano Peris, Filippo Pieralli, Loredana Poggesi, Niccolo Marchionni, Rossella Marcucci |
| 80 |
[GO] |
2020―May―11 |
COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure |
Luca Spiezia, Annalisa Boscolo, Francesco Poletto, Lorenzo Cerruti, Ivo Tiberio, Elena Campello, Paolo Navalesi, Paolo Simioni |
| 81 |
[GO] |
2020―May―06 |
Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines |
Zhenguo Zhai, Chenghong Li, Yaolong Chen, Grigorios Gerotziafas, Zhenlu Zhang, Jun Wan, Peng Liu, Ismaïl Elalamy, Chen Wang |
| 82 |
[GO] |
2020―Apr―29 |
Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified? |
Marco Cattaneo, Elena M. Bertinato, Simone Birocchi, Carolina Brizio, Daniele Malavolta, Marco Manzoni, Gesualdo Muscarella, Michela Orlandi |
| 83 |
[GO] |
2020―Apr―29 |
Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge |
Francesco Violi, Daniele Pastori, Roberto Cangemi, Pasquale Pignatelli, Lorenzo Loffredo |
| 84 |
[GO] |
2020―Apr―04 |
D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis |
Giuseppe Lippi, Emmanuel J. Favaloro |
|
